Harvard Bioscience, Inc. HBIO

7.96 (0.06) (0.75%) as of 25 Sep
Market cap
$36.5M
P/E
0.0×
Insider Buys alert about insiders buying in the last 12 month
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/S ratio
0.34 0.98 2.04 0.98 2.39 1.62 0.99 0.96 1.48 0.95
P/FCF ratio
6.11 0.00 18.70 0.00 0.00 20.27 16.89 61.08 640.70 25.19
P/Operating CF
(309.81) 53.26 53.14 41.43 2,430.92 66.57 51.95 44.71 (122.14) 57.45
P/B ratio
2.17 1.45 3.13 1.54 3.41 2.16 1.41 1.40 1.42 1.37
Price to Tangible BV
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 3.45 6.41
EV/Sales
1.05 1.69 2.32 1.35 2.73 2.01 1.38 1.40 1.57 1.03
EV/EBITDA
13.70 124.87 28.45 166.27 32.60 22.75 18.93 17.77 37.77 78.48
EV/Operating CF
13.52 110.39 18.60 133.08 257.47 22.02 19.99 58.44 114.70 19.95
EV/FCF
18.69 (87.20) 21.34 (260.72) (3,914.78) 25.12 23.55 88.80 677.32 27.26
Quick Ratio
1.12 0.35 0.77 0.91 1.17 1.24 1.15 1.16 1.59 1.75
Current Ratio
2.20 0.82 1.85 2.20 2.43 2.46 2.12 2.27 3.39 3.11
Net Debt/EBITDA
4.11 25.80 3.52 45.90 4.06 4.39 5.35 5.55 2.04 5.96
Debt/Assets
44.80% 29.18% 26.62% 32.21% 29.77% 30.72% 32.64% 36.06% 10.74% 12.76%
Debt/Equity
2.61 0.58 0.50 0.65 0.58 0.63 0.66 0.73 0.15 0.19
Asset Turnover
0.84 0.71 0.79 0.74 0.75 0.64 0.70 0.87 0.71 0.92
Operating CF/Net income
(0.12) (0.12) (4.11) (0.12) (4.38) (1.19) (1.72) (0.99) (1.22) (1.25)
Capex/Depreciation
(0.03) (0.44) (0.25) (0.20) (0.17) (0.16) (0.15) (0.12) (0.23) (0.33)
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
(147.13%) (18.19%) (4.70%) (12.23%) (0.36%) (9.86%) (5.70%) (3.57%) (1.13%) (5.75%)
ROA
(54.86%) (9.40%) (2.42%) (6.19%) (0.18%) (4.86%) (2.81%) (2.10%) (0.80%) (3.78%)
ROIC
(74.07%) (4.04%) 1.12% (3.78%) 1.04% 0.12% 0.19% 0.45% (0.45%) (2.33%)
Return on Tangible Assets
(182.60%) 261.99% (12.90%) (30.46%) (0.73%) (22.57%) (14.19%) (7.64%) (2.32%) (12.25%)
Average Days of Receivables
67.66 57.64 52.35 53.80 67.02 63.51 65.05 64.86 80.59 69.57
Research and Development Expense of Revenue
10.20% 11.05% 10.48% 10.88% 9.08% 8.51% 9.22% 9.10% 7.29% 5.16%
Selling, General and Administrative Expense of Revenue
42.70% 46.43% 41.71% 43.71% 41.17% 42.53% 39.62% 37.94% 42.12% 39.64%
Intangible Assets out of Total Assets
0.21 0.53 0.53 0.53 0.52 0.59 0.58 0.61 0.44 0.53
Share Based Compensation of Revenue
2.14% 4.61% 4.45% 3.89% 3.51% 3.57% 2.61% 2.52% 4.52% 3.35%
Graham Net Nets
(0.61) (0.20) (0.07) (0.20) (0.06) (0.17) (0.26) (0.24) 0.17 0.10
Graham Number
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Yield
(191.04%) (13.74%) (1.40%) (8.58%) (0.20%) (4.78%) (4.00%) (3.05%) (0.61%) (4.48%)
Free Cash Flow Yield
16.36% (1.98%) 5.35% (0.53%) (0.03%) 4.93% 5.92% 1.64% 0.16% 3.97%
Revenue per Share
19.50 21.62 26.46 27.37 29.47 26.42 30.72 33.13 22.27 30.55
Operating CF per Share
1.52 0.33 3.31 0.28 0.31 2.41 2.13 0.79 0.30 1.57
Capex per Share
(0.42) (0.75) (0.42) (0.38) (0.33) (0.36) (0.32) (0.27) (0.25) (0.42)
Free Cash Flow per Share
1.10 (0.42) 2.88 (0.11) (0.02) 2.05 1.81 0.52 0.05 1.15
Cash per Share
1.94 0.94 1.01 1.09 1.94 2.15 2.20 2.24 1.49 1.64
Shareholders Equity per Share
3.09 14.55 17.23 17.44 20.67 19.85 21.60 22.69 23.28 21.10
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
3.09 14.55 17.23 17.44 20.67 19.85 21.60 22.69 23.28 21.10
Free Cash Flow
4.87 (1.82) 12.23 (0.44) (0.08) 7.93 6.83 1.90 0.18 3.94
Working Capital
26.27 (9.84) 22.50 27.88 36.27 30.65 28.26 32.34 33.49 30.87
Capital Expenditures
(1.86) (3.26) (1.80) (1.59) (1.34) (1.40) (1.22) (0.99) (0.88) (1.44)
Net Current Asset Value
(18.11) (18.19) (15.25) (22.02) (17.36) (27.87) (29.60) (28.06) 19.08 9.90
EV/EBIT
0.00 0.00 137.76 0.00 157.27 929.66 426.56 171.28 0.00 0.00
Capex to Sales
0.02 0.03 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01
Net Profit Margin
(65.51%) (13.18%) (3.04%) (8.40%) (0.24%) (7.65%) (4.03%) (2.42%) (1.12%) (4.12%)
Price to Operating Income
0.00 0.00 120.72 0.00 137.67 750.07 305.92 117.81 0.00 0.00
Other line items
Depreciation/Fixed assets
11.54 1.47 1.83 2.33 2.31 2.23 1.70 1.44 1.03 1.02
Cash ROIC
3.34% (3.51%) 8.82% (1.79%) (1.54%) 4.04% 2.27% (1.99%) (2.75%) 1.19%
Accounts Receivable Turnover
5.60 6.08 6.84 5.88 6.01 5.31 5.51 6.27 4.18 5.06
Accounts Payable Turnover
8.68 7.61 7.70 9.25 9.42 7.79 8.17 9.79 7.21 7.49
Inventory Turnover
1.66 1.64 1.81 1.94 2.06 1.99 2.20 2.75 2.08 2.65
Average Days of Payables
36.38 44.38 43.90 44.81 34.97 49.47 37.58 46.64 42.10 40.31
Days of Inventory on Hand
207.26 215.51 195.36 183.76 196.47 184.43 155.29 158.99 160.83 129.82
Average Receivables
15.45 15.48 16.40 19.27 19.80 19.24 21.08 19.28 18.51 20.67
Average Payables
4.22 5.17 6.00 5.68 5.44 5.66 6.35 5.88 5.30 7.49
Average Inventory
22.03 23.98 25.58 27.01 24.92 22.16 23.57 20.97 18.40 21.15
Average Assets
103.36 132.01 141.36 153.85 159.30 160.56 166.74 138.98 108.56 113.91
Average Common Equity
38.54 68.21 72.65 77.81 80.04 79.19 82.21 81.81 76.55 74.90

Fold the line items

Columns are period end dates